Never miss a story

Get subscribed to our newsletter


×
Photo by Firmbee.com on Unsplash

Facebook banned misleading anti-vaccine campaign, from Russia which targeted users of India, US and the Latin America.

By Tharini Ilanchezhian

Facebook has banned about 300 accounts that were found propagating a false message that claimed that the vaccine drug synthesized by the firms AstraZeneca and Pfizer can possibly turn humans into chimpanzees.

Keep Reading Show less

Popular

Photo by Hakan Nural on Unsplash
person holding white and black labeled bottle


By Tharini Ilanchezhian

The Drug Controller General of India, DCGI has given approval to a study to be conducted at the Christian Medical College (CMC),Vellore on mixing the doses of the covid-19 vaccines Covishield and Covaxin, official sources said on Wednesday.

Keep Reading Show less
ians

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) on July 29, recommended for conducting this study on mixing of the two shots.

The Drugs Controller General of India (DCGI) has given a green signal for the task of conducting a study on the mixing of India's two main COVID-19 vaccines, Covaxin and Covishield, news agency ANI reported on Wednesday, 11 August.

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) on July 29, recommended for conducting this study on mixing of the two shots.

The expert committee recommended granting permission to CMC, Vellore, for conducting the Phase-4 clinical trial which may conduct the study on 300 healthy volunteers by administered a dose of each of Covaxin and Covishield.

However, the DCGI's approval for the study on mixing the vaccines is different from the recent study of the Indian Council of Medical Research (ICMR) which concluded that combining two different shots is "safe and effective".
Photo by Unsplash

It means the body can continue making these vital cells long after the antibodies have waned,

The Oxford-AstraZeneca jab gives powerful protection that may last a whole lifetime, a new study has found.

Apart from generating virus-busting antibodies, the vaccine also creates "training camps" in the body for search-and-destroy T-cells which can kill even the new variants, The Sun, UK, reported.

It means the body can continue making these vital cells long after the antibodies have waned, as possible for the rest of your life, it said.

Scientists from Oxford, the UK, and Switzerland, writing in the journal 'Nature', said that T-cell protection is a "key feature" of adenovirus vaccines like the Oxford and J&J jabs.

As per the report, researcher Burkhard Ludewig from Cantonal Hospital in Switzerland said: "The T-cells that come from these cellular training camps appear to have a very high level of 'fitness'.

"Adenoviruses have co-evolved with humans over a very long time and learned a lot about the human immune system in the process.

"Viruses are always the best teachers, and here they have taught us an important lesson about how best to boost killer T-cell responses.

"Hopefully we can put this to good use in designing new vaccines targeting other diseases like TB, HIV, hepatitis C and cancer."

The researchers found that adenoviruses can get into long-lived tissue cells, known as fibroblastic reticular cells, which act as "training grounds" for T-cells.

Previous studies have shown that the Oxford jab is more effective in generating T-cells than mRNA vaccines like Pfizer and Moderna.

T-cell levels are difficult to measure, but the new study gives hope that they may last a lifetime, the report said.

Paul Klenerman from the Nuffield Department of Medicine at Oxford said: "Millions of people have received adenovirus vaccines around the world. The ultimate goal with these vaccines is the induction of long-term immune system protection using both antibodies and T-cells.

Keep reading... Show less